ETHYL_(3-S)-3-[((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)-(HYDROXY)-PHOSPHINYL]-3-TRIFLUOROMETHYLPROPANOATE
Compound with spectra: 1 NMR
![ETHYL_(3-S)-3-[((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)-(HYDROXY)-PHOSPHINYL]-3-TRIFLUOROMETHYLPROPANOATE](/api/compound/39kyoqUIFKR.png?ph=true&h=300&w=458 "ETHYL_(3-S)-3-[((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)-(HYDROXY)-PHOSPHINYL]-3-TRIFLUOROMETHYLPROPANOATE")
| SpectraBase Compound ID | 39kyoqUIFKR |
|---|---|
| InChI | InChI=1S/C19H25F3NO8P/c1-3-30-16(24)11-15(19(20,21)22)32(27,28)10-9-14(17(25)29-2)23-18(26)31-12-13-7-5-4-6-8-13/h4-8,14-15H,3,9-12H2,1-2H3,(H,23,26)(H,27,28)/t14-,15?/m0/s1 |
| InChIKey | YZRLHOQUFFVSDM-MLCCFXAWSA-N |
| Mol Weight | 483.38 g/mol |
| Molecular Formula | C19H25F3NO8P |
| Exact Mass | 483.126988 g/mol |
| Enantiomer InChIKey | YZRLHOQUFFVSDM-GICMACPYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
2-(BENZYLOXYCARBONYLAMINO)-4-(DIETHYLPHOSPHONO)-BUTANOYLLEUCINE-TERT.-BUTYLESTER;Z-ABU(PO3ET2)-LEU-OBU-T
Methyl N-(benzyloxycarbonyl)-2-(bromodifluoromethyl)phenylalaninate
N-(4-Methoxy-benzyloxycarbonyl)-A-(4-methoxy-benzyl-ester)-D-L-A-amino-adipoyl-L-vinyl-glycine-glycine benzhydryl ester
TUWFDMZMEJROJT-CYXNTTPDSA-N
Benzyl 5-[(benzyloxy)carbonyl]-11-[(benzylsulfanyl)methyl]-14-methyl-3,9,12-trioxo-1-phenyl-2-oxa-4,10,13-triazapentadecan-15-oate
BENZYL-(2S)-BENZYLOXYCARBONYLAMINO-3-(5-ACETOXYISOXAZOL-4-YL)-PROPIONATE
CTLNPOOMSUWDMD-DYZYQPBXSA-N
(2S)-2-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]-4-[2-oxo-4-(phenylmethoxycarbonylamino)-1-pyrimidinyl]butanoic acid methyl ester
Z-Arginyl(Z2)-glycine benzyl ester
Benzyloxycarbonyl-leucyl-(p-benzyloxy)phenylalanine, t-butyl ester
| Title | Journal or Book | Year |
|---|---|---|
| A Virtual Screening Hit Reveals New Possibilities for Developing Group III Metabotropic Glutamate Receptor Agonists | Journal of Medicinal Chemistry | 2010 |